Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation.

[1]  M. Wilhelm,et al.  The MYCN oncogene and differentiation in neuroblastoma. , 2011, Seminars in cancer biology.

[2]  S. Påhlman,et al.  Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage. , 2011, Seminars in cancer biology.

[3]  K. Matthay,et al.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  John M. Maris,et al.  High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma , 2008, Proceedings of the National Academy of Sciences.

[5]  M. Pool,et al.  NeuriteTracer: A novel ImageJ plugin for automated quantification of neurite outgrowth , 2008, Journal of Neuroscience Methods.

[6]  F. Murakami,et al.  The role of Slit-Robo signaling in the generation, migration and morphological differentiation of cortical interneurons. , 2008, Developmental biology.

[7]  Andrew G. Hall,et al.  Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data , 2007, Oncogene.

[8]  M. Cole,et al.  p53 is Nuclear and Functional in Both Undifferentiated and Differentiated Neuroblastoma , 2007, Cell cycle.

[9]  B. Hero,et al.  Neuroblastoma , 2007, The Lancet.

[10]  J. Lunec,et al.  Cell Cycle Regulation Targets of MYCN Identified by Gene Expression Microarrays , 2007, Cell cycle.

[11]  M. Fukuzawa,et al.  Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. , 2007, International journal of oncology.

[12]  A. Hall,et al.  High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. , 2007, Cancer genetics and cytogenetics.

[13]  D. Chung,et al.  MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. , 2006, Biochemical and biophysical research communications.

[14]  U. Kees,et al.  The Role of MYCN in the Failure of MYCN Amplified Neuroblastoma Cell Lines to G1 Arrest After DNA Damage , 2006, Cell cycle.

[15]  Barbara Hero,et al.  Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome , 2006, Clinical Cancer Research.

[16]  U. Kees,et al.  Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse. , 2006, Cancer research.

[17]  R. Ross,et al.  Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells , 2006, Oncogene.

[18]  Yoshiki Katayama,et al.  Differences in gene expression profile among SH‐SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor , 2005, Journal of neurochemistry.

[19]  S. Ishii,et al.  Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. , 2005, Cancer cell.

[20]  Qing-Rong Chen,et al.  Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma , 2004, Cancer Research.

[21]  W. Andrews,et al.  Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding , 2004, Molecular and Cellular Neuroscience.

[22]  S. U. Kim,et al.  Retinoic acid‐mediated induction of neurons and glial cells from human umbilical cord‐derived hematopoietic stem cells , 2004, Journal of neuroscience research.

[23]  R. Versteeg,et al.  Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. , 2004, Gene.

[24]  Y. Kwong,et al.  Differential effects of 9-cis, 13-cis and all-trans retinoic acids on the neuronal differentiation of human neuroblastoma cells , 2003, Neuroreport.

[25]  E. Fisher,et al.  Microcell-mediated chromosome transfer (MMCT): small cells with huge potential , 2003, Mammalian Genome.

[26]  S. Sugano,et al.  Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets , 2003, Oncogene.

[27]  Barbara Hero,et al.  Neuroblastoma: biology and molecular and chromosomal pathology. , 2003, The Lancet. Oncology.

[28]  O. Gavet,et al.  Regulation and subcellular localization of the microtubule‐destabilizing stathmin family phosphoproteins in cortical neurons , 2002, Journal of neuroscience research.

[29]  Hiroyuki Shimada,et al.  Morphologic features of neuroblastoma (Schwannian stroma‐poor tumors) in clinically favorable and unfavorable groups , 2002, Cancer.

[30]  Hiroyuki Shimada,et al.  Terminology and morphologic criteria of neuroblastic tumors , 1999, Cancer.

[31]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[32]  P. Worley,et al.  Neuronal Activity Induction of the Stathmin-Like Gene RB3 in the Rat Hippocampus: Possible Role in Neuronal Plasticity , 1998, The Journal of Neuroscience.

[33]  F. Roisen,et al.  Ganglioside GM1 alters neuronal morphology by modulating the association of MAP2 with microtubules and actin filaments. , 1998, Brain research. Developmental brain research.

[34]  F. Speleman,et al.  Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. , 1995, Human molecular genetics.

[35]  E. Stanbridge,et al.  Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  H. Banfić,et al.  Cell Growth and Differentiation , 2008 .

[37]  P. Lovat,et al.  Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells. , 2001, Medical and pediatric oncology.

[38]  L. Grimelius,et al.  Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[39]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.